These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 15834538)

  • 1. 5-HT2A/2C receptor signaling via phospholipase A2 and arachidonic acid is attenuated in mice lacking the serotonin reuptake transporter.
    Qu Y; Villacreses N; Murphy DL; Rapoport SI
    Psychopharmacology (Berl); 2005 Jun; 180(1):12-20. PubMed ID: 15834538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic lithium administration to rats selectively modifies 5-HT2A/2C receptor-mediated brain signaling via arachidonic acid.
    Basselin M; Chang L; Seemann R; Bell JM; Rapoport SI
    Neuropsychopharmacology; 2005 Mar; 30(3):461-72. PubMed ID: 15562295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional interactions between 5-HT2A and presynaptic 5-HT1A receptor-based responses in mice genetically deficient in the serotonin 5-HT transporter (SERT).
    Fox MA; Stein AR; French HT; Murphy DL
    Br J Pharmacol; 2010 Feb; 159(4):879-87. PubMed ID: 20128812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging brain phospholipase A2 activation in awake rats in response to the 5-HT2A/2C agonist (+/-)2,5-dimethoxy-4-iodophenyl-2-aminopropane (DOI).
    Qu Y; Chang L; Klaff J; Balbo A; Rapoport SI
    Neuropsychopharmacology; 2003 Feb; 28(2):244-52. PubMed ID: 12589377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging elevated brain arachidonic acid signaling in unanesthetized serotonin transporter (5-HTT)-deficient mice.
    Basselin M; Fox MA; Chang L; Bell JM; Greenstein D; Chen M; Murphy DL; Rapoport SI
    Neuropsychopharmacology; 2009 Jun; 34(7):1695-709. PubMed ID: 19145225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in mice.
    Halberstadt AL; van der Heijden I; Ruderman MA; Risbrough VB; Gingrich JA; Geyer MA; Powell SB
    Neuropsychopharmacology; 2009 Jul; 34(8):1958-67. PubMed ID: 19322172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The serotonin 5-HT(2A) receptor agonist TCB-2: a behavioral and neurophysiological analysis.
    Fox MA; French HT; LaPorte JL; Blackler AR; Murphy DL
    Psychopharmacology (Berl); 2010 Sep; 212(1):13-23. PubMed ID: 19823806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging of brain serotonergic neurotransmission involving phospholipase A2 activation and arachidonic acid release in unanesthetized rats.
    Qu Y; Chang L; Klaff J; Seeman R; Balbo A; Rapoport SI
    Brain Res Brain Res Protoc; 2003 Aug; 12(1):16-25. PubMed ID: 12928041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen.
    Canal CE; Olaghere da Silva UB; Gresch PJ; Watt EE; Sanders-Bush E; Airey DC
    Psychopharmacology (Berl); 2010 Apr; 209(2):163-74. PubMed ID: 20165943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute serotonin 2A receptor activation impairs behavioral flexibility in mice.
    Amodeo DA; Hassan O; Klein L; Halberstadt AL; Powell SB
    Behav Brain Res; 2020 Oct; 395():112861. PubMed ID: 32814148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Support for 5-HT2C receptor functional selectivity in vivo utilizing structurally diverse, selective 5-HT2C receptor ligands and the 2,5-dimethoxy-4-iodoamphetamine elicited head-twitch response model.
    Canal CE; Booth RG; Morgan D
    Neuropharmacology; 2013 Jul; 70():112-21. PubMed ID: 23353901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors.
    Moya PR; Berg KA; Gutiérrez-Hernandez MA; Sáez-Briones P; Reyes-Parada M; Cassels BK; Clarke WP
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1054-61. PubMed ID: 17337633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that genetic variation in 5-HT transporter expression is linked to changes in 5-HT2A receptor function.
    Jennings KA; Sheward WJ; Harmar AJ; Sharp T
    Neuropharmacology; 2008 Apr; 54(5):776-83. PubMed ID: 18241894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic fluoxetine upregulates arachidonic acid incorporation into the brain of unanesthetized rats.
    Qu Y; Chang L; Klaff J; Seemann R; Greenstein D; Rapoport SI
    Eur Neuropsychopharmacol; 2006 Dec; 16(8):561-71. PubMed ID: 16517130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in 5-HT2A-mediated behavior and 5-HT2A- and 5-HT1A receptor binding and expression in conditional brain-derived neurotrophic factor knock-out mice.
    Klein AB; Santini MA; Aznar S; Knudsen GM; Rios M
    Neuroscience; 2010 Sep; 169(3):1007-16. PubMed ID: 20576498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro autoradiography of serotonin 5-HT(2A/2C) receptor-activated G protein: guanosine-5'-(gamma-[(35)S]thio)triphosphate binding in rat brain.
    Adlersberg M; Arango V; Hsiung S; Mann JJ; Underwood MD; Liu K; Kassir SA; Ruggiero DA; Tamir H
    J Neurosci Res; 2000 Sep; 61(6):674-85. PubMed ID: 10972964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT2A/2C receptor and 5-HT transporter densities in mice prone or resistant to chronic high-fat diet-induced obesity: a quantitative autoradiography study.
    Huang XF; Huang X; Han M; Chen F; Storlien L; Lawrence AJ
    Brain Res; 2004 Aug; 1018(2):227-35. PubMed ID: 15276882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-hydroxytryptamine2C receptor activation inhibits 5-hydroxytryptamine1B-like receptor function via arachidonic acid metabolism.
    Berg KA; Maayani S; Clarke WP
    Mol Pharmacol; 1996 Oct; 50(4):1017-23. PubMed ID: 8863849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin 5-HT2A receptors underlie increased motor behaviors induced in dopamine-depleted rats by intrastriatal 5-HT2A/2C agonism.
    Bishop C; Tessmer JL; Ullrich T; Rice KC; Walker PD
    J Pharmacol Exp Ther; 2004 Aug; 310(2):687-94. PubMed ID: 15044557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovering the mechanisms underlying serotonin (5-HT)2A and 5-HT2C receptor regulation following nicotine withdrawal in rats.
    Zaniewska M; Alenina N; Wydra K; Fröhler S; Kuśmider M; McCreary AC; Chen W; Bader M; Filip M
    J Neurochem; 2015 Aug; 134(4):704-16. PubMed ID: 26031442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.